NasdaqGM - Nasdaq Real Time Price USD

Olink Holding AB (publ) (OLK)

22.07 -0.20 (-0.90%)
As of 2:56 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Jon Heimer CEO & Director 889.39k -- 1967
Mr. Carl Raimond Interim Chief Commercial Officer & President -- -- 1971
Mr. Oskar Hjelm Chief Financial Officer -- -- 1985
Ms. Anna Marsell Chief Operating Officer -- -- 1978
Mr. Jan Medina CFA Vice President of Investor Relations & Capital Markets -- -- --
Ms. Linda Ramirez-Eaves Esq. General Counsel -- -- 1972
Andrea Prander Corporate Communications Manager -- -- --
Mr. Elias Berglund Chief People Officer -- -- 1978
Mr. Rickard El Tarzi Chief Strategy & Product Officer -- -- 1986
Ms. Maria Liminga Bjork Chief Research & Development Officer -- -- 1969

Olink Holding AB (publ)

Salagatan 16F
Uppsala, 753 30
Sweden
46 1 84 44 39 70 https://www.olink.com
Sector: 
Healthcare
Full Time Employees: 
707

Description

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Corporate Governance

Olink Holding AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 09, 2024 - May 13, 2024
Olink Holding AB (publ) Earnings Call

Related Tickers

MYGN Myriad Genetics, Inc.
18.30
-1.13%
 
RVTY Revvity, Inc.
100.79
+1.41%
 
BNR Burning Rock Biotech Limited
0.7020
-12.25%
 
4544.T H.U. Group Holdings, Inc.
2,326.50
-1.63%
 
VCYT Veracyte, Inc.
19.20
-0.03%
 
300676.SZ BGI Genomics Co., Ltd.
38.08
-0.96%
 
QGEN Qiagen N.V.
40.06
+1.49%
 
LAB Standard BioTools Inc.
2.5100
-1.18%
 
CSTL Castle Biosciences, Inc.
19.04
-0.83%
 
PMD Psychemedics Corporation
2.6300
+3.14%